Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting

Objective biomarkers for Parkinson’s Disease (PD) could aid early and specific diagnosis, effective monitoring of disease progression, and improved design and interpretation of clinical trials. Although alpha-synuclein remains a biomarker candidate of interest, the multifactorial and heterogenous na...

Descripción completa

Detalles Bibliográficos
Autores principales: Youssef, Priscilla, Hughes, Laura, Kim, Woojin S., Halliday, Glenda M., Lewis, Simon J. G., Cooper, Antony, Dzamko, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063670/
https://www.ncbi.nlm.nih.gov/pubmed/36997567
http://dx.doi.org/10.1038/s41598-023-32480-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063670/
https://www.ncbi.nlm.nih.gov/pubmed/36997567
http://dx.doi.org/10.1038/s41598-023-32480-0

Ejemplares similares